Location History:
- both Ann Arbor, MI (US) (1990)
- Ann Arbor, MI (US) (2003 - 2021)
Company Filing History:
Years Active: 1990-2021
Title: Roy Clarke: Innovator in Optical Probes and Detection Technologies
Introduction
Roy Clarke is a distinguished inventor based in Ann Arbor, MI, with a remarkable portfolio of 12 patents. His work primarily focuses on advancements in optical probes and detection technologies, particularly in the fields of radiotherapy and nuclear material detection.
Latest Patents
One of Clarke's latest patents is the development of silicon photomultiplier array-based multispectral optical probes for image-guided radiotherapy. This innovation utilizes Cerenkov Emission (CE) during external beam radiation therapy (EBRT) from a linear accelerator (Linac) to enhance radiotherapy quality assurance. The technology aims to improve the detection sensitivity of CE and provide flexible tools for monitoring tumor status during treatment. Additionally, Clarke's optoelectronic neutron detector is designed to detect nuclear material by utilizing a neutron capture and scatter medium that produces secondary charged particles. This detector includes a photodetector that identifies emitted light and provides alerts regarding detected nuclear material.
Career Highlights
Clarke has made significant contributions to the field through his work at the University of Michigan and K-Space Associates, Inc. His innovative approaches have led to advancements in both medical and security applications, showcasing his versatility as an inventor.
Collaborations
Throughout his career, Clarke has collaborated with notable individuals such as Charles A. Taylor, II and Darryl Barlett. These partnerships have further enriched his research and development efforts.
Conclusion
Roy Clarke's contributions to optical probes and detection technologies exemplify his commitment to innovation. His patents reflect a deep understanding of complex scientific challenges and a dedication to improving both medical treatments and safety measures.